www.healthcarepackaging.com

www.healthcarepackaging.com
Share

Back in early 2014, then Healthcare Packaging Publisher Jim Chrzan and yours truly traveled to Washington, DC, making stops at the Parenteral Drug Assn., the U.S. Pharmacopeial Convention, the Regulatory Affairs Professionals Society and the Consumer Products Safety Commission, to learn about and report on life science packaging-related...

According to a recent in-Pharma Technologist article, the FDA issued a warning letter to China’s Lumis Global Pharmaceuticals following an inspection of the company’s active pharmaceutical ingredient (API) plant in Wuhan Hubei. The letter states, “You omitted the name and address of the original API manufacturers on the certificates of analysis...

www.healthcarepackaging.com

 •  February 14

Consumers give global pharmaceutical companies an average reputation and express uncertainty about what those companies stand for, according to a new survey of corporate reputations. (Related: Addressing Serialization and Aggregation Head-On) A top driver of reputation in the pharmaceutical industry is governance, or being a responsibly run company...

www.healthcarepackaging.com

 •  February 14

In July, OrthoStreams, a daily orthopedic news and commentary website, reported that China became the second-largest medical device market in the world, trailing only the U.S., although other reports put Japan in the number-two position. (Related: Addressing Serialization and Aggregation Head-On) “China is home to nearly one-fifth of the world’s...